Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefitinib in Recurrent Prostate Cancer
NCT00635856Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- May 2001
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of gefitinib in prostate cancer (PCa), sponsored by AstraZeneca. Started May 2001; status: completed.
02
Drugs
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00635856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00635856.